Sol-Gel Technologies Ltd. (SLGL)
NASDAQ: SLGL · Real-Time Price · USD
64.25
-4.45 (-6.48%)
At close: Oct 16, 2026, 4:00 PM EDT
64.15
-0.10 (-0.16%)
After-hours: Oct 16, 2026, 7:30 PM EDT
Sol-Gel Technologies Market Cap
Sol-Gel Technologies has a market cap or net worth of $210.35 million as of October 16, 2026. It is the 20,474th most valuable company in the world and the 3,538th biggest in the United States. Its market cap has increased by 80.87% in one year.
Market Cap
210.35M
Enterprise Value
163.20M
1-Year Change
80.87%
Global Rank
Country Rank
#3,538 United States
Category
ChartMarket Cap Chart
Since February 1, 2018, Sol-Gel Technologies's market cap has decreased from $228.30M to $210.35M, a decrease of -7.86%. That is a compound annual growth rate of -0.94%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 16, 2026 | 210.40M | 79.22% |
| Dec 31, 2025 | 117.40M | 353.28% |
| Dec 31, 2024 | 25.90M | -15.91% |
| Dec 29, 2023 | 30.80M | -70.81% |
| Dec 30, 2022 | 105.50M | -38.34% |
| Dec 31, 2021 | 171.10M | -24.02% |
| Dec 31, 2020 | 225.20M | -35.58% |
| Dec 31, 2019 | 349.60M | 206.94% |
| Dec 31, 2018 | 113.90M | -50.11% |
| Feb 1, 2018 | 228.30M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Lexeo Therapeutics | 216.59M |
| Vogenx | 215.84M |
| Fate Therapeutics | 214.48M |
| Greenwich LifeSciences | 213.57M |
| Keros Therapeutics | 211.36M |
| Protalix BioTherapeutics | 211.10M |
| Larimar Therapeutics | 208.77M |
| MacroGenics | 207.03M |